Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)
Go back to Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)| (NASDAQ: CMPX) | Delayed: 2.02 -0.04 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.06 | 52 Week High | $ | |||
| Open | $2.06 | 52 Week Low | $ | |||
| Day High | $2.10 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $ | |||
| Volume | 3,137,852 | |||||
